Horizon CEO, Joel White, spoke with BioSpace about what a Trump presidency could mean for the Inflation Reduction Act (IRA). Joel White, a Republican healthcare strategist, told BioSpace that the bureaucracy surrounding […]
Horizon’s CEO, Joel White, spoke with Politico about rising Medicare premiums and their impact on the 2024 presidential election. Even as voters say inflation and health care costs are a […]
Horizon’s Joel White spoke with Axios for its article, “How Trump could weaken Medicare drug pricing negotiations.” The article focuses on how if Donald Trump is re-elected, he could get […]
Horizon’s CEO was interviewed by Inside Health Policy about the timeline for passing healthcare legislation, including PBM reforms. Given the amount of time lawmakers spent to introduce and pass legislation […]
Horizon CEO Joel White spoke with Politico about the new Speaker of the House, where he stands on healthcare, and the important role committee leaders will play in pushing through […]
More and more states are mirroring federal policies on drugs. States have expanded their sights to regulate PBMs, drug access, and drug manufacturers. 2024 promises to bring even more efforts […]
Horizon’s CEO, Joel White, recently had lunch with Peter Sullivan where he shared stories about his time working in Congress and his favorite places to go to on Capitol Hill. […]